Drew Spaventa, MBA
Founder and Chief Executive Officer, Singular Genomics
Drew is the founder and chief executive officer at Singular Genomics. Drew is also founder and managing partner at Axon Ventures, which has made early stage investments in a number of local companies and several other early stage stealth biotech startups. Prior to his Singular Genomics, Drew was a seed investor and part of the founding team at ecoATM, which was acquired for $350 million. He was also a seed investor and consultant at Edico Genome, acquired by Illumina for $100 million.
Drew has a bachelor’s degree from UC San Diego, an MBA from The Rady School of Management and partial completion of JD at USD.